UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).

Oklo's monster run reflects rising market optimism for small reactors -- and their potential role in powering AI computing. But execution won't come easily.

Technology is not what powers a data-first culture, but people, operating models, and disciplined delivery. Most organizations already possess more tools and data than they can effectively utilize.

XYO launched its own Layer One blockchain to handle massive amounts of data for DePIN, AI, and real-world asset (RWA) ...

YieldMax MSFT Option Income Strategy ETF offers an aggressive ~32% yield via a buywrite strategy. Click here to read why I ...

LinkDaddy has launched its proprietary Backlink Strategy Report (BSR), a data-driven system that eliminates SEO guesswork.

Ram Chella speaks about the impact of AI-led transformation in colleges, for students to see what readiness looks like, and ...

KALISPELL, MT / ACCESS Newswire / September 13, 2025 / DealHurryUp, a popular discount-aggregation website that collects Amazon deals so shoppers no longer have to pay full price, today announced a ma ...

Shiba Inu (SHIB) and Pepe coin (PEPE) have long dominated meme coin chatter. However, many analysts are now pointing to a newcomer for potential weekend ...

ASX healthcare sector remains under pressure as Telix reaches FDA deal on pathway to resubmit marketing application for ...

"Winning the Daily #1 was an incredible validation of the proble we're solving," said Steven Cen, Product Manager at Ada. "To ...